Rocket Pharmaceuticals Inc (RCKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Operating Expenses | 20,396 | 7,704 | 6,654 | 5,849 | 0 |
| Operating Income | -20,396 | -7,704 | -6,654 | -5,849 | N/A |
| Interest Expense | 1,230 | 980 | 884 | 213 | 0 |
| Other Income | -46,356 | -847 | -78 | 4 | 0 |
| Pre-tax Income | -67,982 | -9,531 | -7,616 | -6,058 | 0 |
| Net Income Continuous | -67,982 | -9,531 | -7,616 | -6,058 | N/A |
| Net Income | $-67,982 | $-9,531 | $-7,616 | $-6,058 | $N/A |
| EPS Basic Total Ops | -14.88 | -54.08 | -40.20 | -32.16 | N/A |
| EPS Basic Continuous Ops | -14.85 | -37.37 | -29.92 | -23.84 | N/A |
| EPS Diluted Total Ops | -14.88 | -54.08 | -40.20 | -32.16 | N/A |
| EPS Diluted Continuous Ops | -14.85 | -37.37 | -29.92 | -23.84 | N/A |
| EBITDA(a) | $-20,276 | $-7,704 | $-6,654 | $-5,840 | $N/A |